Drugs / Monovalent Influenza A/H5N8 vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03014310 | Jan 2017 → Dec 2018 | avian influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Monovalent Influenza A/H5N8 vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03014310 ↗ |
| Modality | Vaccine | “monovalent inactivated influenza A/H5N8 virus vaccine” NCT03014310 ↗ |
| Route | Intramuscular | “Monovalent inactivated influenza A/H5N8 virus vaccine for IM injection.” NCT03014310 ↗ |